Ozols RF - Search Results

1

Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer.

O'Dwyer PJ, Hamilton TC, LaCreta FP, Gallo JM, Kilpatrick D, Halbherr T, Brennan J, Bookman MA, Hoffman J, Young RC, Comis RL, Ozols RF. O'Dwyer PJ, et al. Among authors: ozols rf. J Clin Oncol. 1996 Jan;14(1):249-56. doi: 10.1200/JCO.1996.14.1.249. J Clin Oncol. 1996. PMID: 8558205 Clinical Trial.

2

Histologic grade in advanced ovarian cancer.

Ozols RF, Garvin AJ, Costa J, Simon RM, Young RC. Ozols RF, et al. Cancer Treat Rep. 1979 Feb;63(2):255-63. Cancer Treat Rep. 1979. PMID: 109199 Clinical Trial.

3

Chemotherapy for murine ovarian cancer: a rationale for ip therapy with adriamycin.

Ozols RF, Locker GY, Doroshow JH, Grotzinger KR, Myers CE, Fisher RI, Young RC. Ozols RF, et al. Cancer Treat Rep. 1979 Feb;63(2):269-73. Cancer Treat Rep. 1979. PMID: 445504

4

Kinetic characterization and response to chemotherapy in a transplantable murine ovarian cancer.

Ozols RF, Grotzinger KR, Fisher RI, Myers CE, Young RC. Ozols RF, et al. Cancer Res. 1979 Aug;39(8):3202-8. Cancer Res. 1979. PMID: 455304 No abstract available.

5

Advances in the chemotherapy of gynecologic malignancies.

Ozols RF. Ozols RF. Hematol Oncol. 1992 Jan-Feb;10(1):43-51. doi: 10.1002/hon.2900100109. Hematol Oncol. 1992. PMID: 1348719 Review.

6

Role of chemotherapy in the future treatment of ovarian cancer.

Ozols RF. Ozols RF. Acta Obstet Gynecol Scand Suppl. 1992;155:55-60. doi: 10.1111/j.1600-0412.1992.tb00007.x. Acta Obstet Gynecol Scand Suppl. 1992. PMID: 1354405 Review.

7

New developments with carboplatin in the treatment of ovarian cancer.

Ozols RF. Ozols RF. Semin Oncol. 1992 Feb;19(1 Suppl 2):85-9. Semin Oncol. 1992. PMID: 1411631 Review.

8

Evaluation of in vitro drug screening leads using experimental models of human ovarian cancer.

Louie KG, Hamilton TC, Shoemaker RH, Young RC, Ozols RF. Louie KG, et al. Among authors: ozols rf. Invest New Drugs. 1992 Jul;10(2):73-8. doi: 10.1007/BF00873120. Invest New Drugs. 1992. PMID: 1500268

9

Phase II study of amonafide in advanced and recurrent sarcoma patients.

Perez RP, Nash SL, Ozols RF, Comis RL, O'Dwyer PJ. Perez RP, et al. Among authors: ozols rf. Invest New Drugs. 1992 Jul;10(2):99-101. doi: 10.1007/BF00873125. Invest New Drugs. 1992. PMID: 1500272 Clinical Trial.

10

Chemotherapy for advanced epithelial ovarian cancer.

Ozols RF. Ozols RF. Hematol Oncol Clin North Am. 1992 Aug;6(4):879-94. Hematol Oncol Clin North Am. 1992. PMID: 1500391 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters